Medical College of Georgia Hoping Austrian Drug Comes over to America for COVID-19 Clinical Trials

Medical researchers in the State of Georgia believe they have locked in on a  game-changing treatment for at least severe cases of COVID-19 involving acute respiratory distress syndrome (ARDS) and pulmonary edema. The Augusta University (AU) Medical College of Georgia...

Austrian Biotech’s Investigational Phase II Drug Receives Compassionate Use Approval for COVID-19 ARDS

About 20% of those hospitalized with COVID-19 suffer from acute respiratory distress syndrome (ARDS), a potentially life-threatening complication of the infection with SARS-CoV-2. Consequently, an Austrian biotech has received compassionate use approval from the...

Pin It on Pinterest